Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome

Phase 2 Completed 104 enrolled Redwood Pharma AB Cross Research S.A. · collab

RandomizedParallel-groupQuadruple-blindTreatment

The main purpose of this study is to establish whether RP101 can reduce symptoms of dry eye syndrome in post-menopausal women.

Evaluation	Drug	Modality	Dose	Route
Subject	Brivudine	Small molecule	0.05 %	Topical
Subject	Brivudine	Small molecule	0.1 %	Topical